NR1H4 | Nuclear receptor subfamily 1, group H, member 4 | Nuclear receptors Transcription factors
| ![](/images/47699/ihc_selected_60x60.jpg) | ![](/images/47699/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/47699/106935_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
OGDHL | Oxoglutarate dehydrogenase-like | Citric acid cycle related proteins Mitochondrial proteins
| | ![](/images/52497/if_selected_60x60.jpg) | ![](/images/52497/ihc_cell_selected_60x60.jpg) | ![](/images/52497/126993_B_6_6_rna_selected_60x60.jpg) | Tissue enhanced |
ONECUT1 | One cut homeobox 1 | Transcription factors
| ![](/images/3457/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/3457/ihc_cell_selected_60x60.jpg) | ![](/images/3457/10482_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
OSGIN1 | Oxidative stress induced growth inhibitor 1 | | ![](/images/19239/ihc_selected_60x60.jpg) | ![](/images/19239/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/19239/44715_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
OXT | Oxytocin/neurophysin I prepropeptide | Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
PAH | Phenylalanine hydroxylase | Disease related genes Enzymes FDA approved drug targets
| | | ![](/images_static/rna_center.gif) | ![](/images/28407/59771_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
PANK1 | Pantothenate kinase 1 | Enzymes
| ![](/images/21795/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/21795/48640_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
PAQR9 | Progestin and adipoQ receptor family member IX | Predicted membrane proteins
| ![](/images/52798/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/52798/124207_B_7_6_rna_selected_60x60.jpg) | Tissue enhanced |
PCK1 | Phosphoenolpyruvate carboxykinase 1 (soluble) | Citric acid cycle related proteins Disease related genes Enzymes Potential drug targets
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/6277/18455_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
PCSK6 | Proprotein convertase subtilisin/kexin type 6 | Enzymes
| ![](/images/4774/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4774/13935_B_1_2_rna_selected_60x60.jpg) | Tissue enhanced |
PCSK9 | Proprotein convertase subtilisin/kexin type 9 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| ![](/images/25575/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25575/54047_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
PKLR | Pyruvate kinase, liver and RBC | Disease related genes Enzymes Plasma proteins Potential drug targets
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/34376/117526_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
PLA1A | Phospholipase A1 member A | Predicted secreted proteins RAS pathway related proteins
| ![](/images/58981/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/58981/133985_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
PLCXD2 | Phosphatidylinositol-specific phospholipase C, X domain containing 2 | | ![](/images/55947/ihc_selected_60x60.jpg) | ![](/images/55947/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/55947/127289_B_6_5_rna_selected_60x60.jpg) | Tissue enhanced |
PNPLA3 | Patatin-like phospholipase domain containing 3 | Disease related genes Enzymes Plasma proteins Potential drug targets
| ![](/images/58058/ihc_selected_60x60.jpg) | ![](/images/58058/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/58058/140162_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
PROS1 | Protein S (alpha) | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images/23974/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/23974/53791_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
PROX1 | Prospero homeobox 1 | Plasma proteins Transcription factors
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
PSAT1 | Phosphoserine aminotransferase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | ![](/images_static/rna_center.gif) | ![](/images/40567/151878_A_4_6_rna_selected_60x60.jpg) | Tissue enhanced |
RBP5 | Retinol binding protein 5, cellular | Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/38723/81034_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
REEP6 | Receptor accessory protein 6 | Predicted membrane proteins
| ![](/images/48015/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48015/145247_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
RELN | Reelin | Disease related genes Plasma proteins Predicted secreted proteins
| ![](/images/4556/ihc_selected_60x60.jpg) | ![](/images/46512/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/4556/13013_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
RND1 | Rho family GTPase 1 | Cytoskeleton related proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
RP11-10A14.4 | Uncharacterized protein | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
RP11-407N17.3 | CTAGE family member 5 isoform 4 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/922/1747_B_7_6_rna_selected_60x60.jpg) | Tissue enhanced |
RP11-422N16.3 | Uncharacterized protein | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
RP11-986E7.7 | | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
SEC14L2 | SEC14-like 2 (S. cerevisiae) | | ![](/images/64466/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/64466/150405_A_1_2_rna_selected_60x60.jpg) | Tissue enhanced |
SEC14L3 | SEC14-like 3 (S. cerevisiae) | Predicted secreted proteins
| ![](/images/59450/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/59450/ihc_cell_selected_60x60.jpg) | ![](/images/59450/133393_B_1_2_rna_selected_60x60.jpg) | Tissue enhanced |
SERPINA4 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/3607/ihc_cell_selected_60x60.jpg) | ![](/images/3607/10872_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
SERPINA5 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images/56919/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/56919/129395_A_2_6_rna_selected_60x60.jpg) | Tissue enhanced |
SERPINE1 | Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| ![](/images/50039/ihc_selected_60x60.jpg) | ![](/images/50039/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/50039/119362_A_4_8_rna_selected_60x60.jpg) | Tissue enhanced |
SHBG | Sex hormone-binding globulin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
SLC10A5 | Solute carrier family 10, member 5 | Predicted membrane proteins Transporters
| ![](/images/25966/ihc_selected_60x60.jpg) | ![](/images/25966/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/25966/55786_A_2_1_rna_selected_60x60.jpg) | Tissue enhanced |
SLC16A13 | Solute carrier family 16, member 13 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
SLC22A3 | Solute carrier family 22 (organic cation transporter), member 3 | Predicted membrane proteins Transporters
| ![](/images/29750/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29750/62085_B_9_5_rna_selected_60x60.jpg) | Tissue enhanced |
SLC25A15 | Solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15 | Disease related genes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| ![](/images/42146/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42146/103685_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
SLC30A10 | Solute carrier family 30, member 10 | Predicted membrane proteins Transporters
| ![](/images/17989/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17989/41249_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
SLC6A12 | Solute carrier family 6 (neurotransmitter transporter), member 12 | Predicted membrane proteins Transporters
| ![](/images/34973/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/34973/70430_B_2_1_rna_selected_60x60.jpg) | Tissue enhanced |
SLC7A2 | Solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 | Predicted membrane proteins Transporters
| ![](/images/9169/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9169/24159_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
STEAP3 | STEAP family member 3, metalloreductase | Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/50510/112903_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
SULT2A1 | Sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | Enzymes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18755/41726_B_2_3_rna_selected_60x60.jpg) | Tissue enhanced |
THRSP | Thyroid hormone responsive | | ![](/images/40642/ihc_selected_60x60.jpg) | ![](/images/40642/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/40642/90389_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
TMEM56 | Transmembrane protein 56 | Predicted membrane proteins
| ![](/images/46762/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46762/109238_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
TMEM56-RWDD3 | TMEM56-RWDD3 readthrough | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
TMPRSS9 | Transmembrane protease, serine 9 | Enzymes Predicted membrane proteins
| ![](/images/51483/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51483/122624_B_6_8_rna_selected_60x60.jpg) | Tissue enhanced |
TRIM55 | Tripartite motif containing 55 | Predicted membrane proteins
| ![](/images/38793/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/38793/81804_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
TSKU | Tsukushi, small leucine rich proteoglycan | Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/8164/22022_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
TSLP | Thymic stromal lymphopoietin | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
UGT1A6 | UDP glucuronosyltransferase 1 family, polypeptide A6 | Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9819/33139_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
UGT1A8 | UDP glucuronosyltransferase 1 family, polypeptide A8 | Enzymes Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |